13 years 🥳 of Publication, 100k+ Stories, 30+ Countries
Search
The Latest News from All Areas of Deals
Latham & Watkins Advises on Arrowhead Pharmaceuticals’ US$450 Million Underwritten Offering of Common Stock
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) has announced the pricing of an underwritten registered offering of 15,790,000 shares of its common…
Latham & Watkins Advises Nalu Medical in Equity Financing Round
Nalu Medical, Inc. (Nalu), a private company focused on innovative, minimally invasive, and non-opioid solutions for chronic neuropathic pain, has…
Latham & Watkins Advises Level Access in Acquisition of UserWay
Level Access, a leading provider of digital accessibility solutions, and UserWay (TASE: UWAY), a pioneer in accessibility AI technologies, announced…
Latham & Watkins Advises on USI, Inc.’s US$620 Million Senior Notes Offering
On December 29, 2023, USI, Inc., one of the largest insurance brokers and a leading middle market broker in the…
Latham & Watkins Advises Diversified Energy in Sustainability-Linked Securitized Financing
Diversified Energy Company (LSE: DEC) (NYSE:DEC) has announced the closing of its asset-backed securitization (ABS) of assets with features aligned…
Kirkland Counsels Forward Consumer Partners on Close of Debut Fund at $425 Million Hard Cap
Kirkland & Ellis advised private equity firm Forward Consumer Partners, a private equity firm that invests in branded consumer businesses, on…
